KalVista Pharmaceuticals (KALV) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -11.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -11.97% |
| Apr 30, 2025 | -3.00% |
| Oct 31, 2024 | -2.20% |
| Jul 31, 2024 | 2.61% |
| Apr 30, 2024 | 7.53% |
| Jan 31, 2024 | 9.06% |
| Oct 31, 2023 | 9.82% |
| Jul 31, 2023 | 11.69% |
| Apr 30, 2023 | 13.00% |
| Jan 31, 2023 | 10.35% |
| Oct 31, 2022 | 8.97% |
| Jul 31, 2022 | 10.35% |
| Apr 30, 2022 | -3.36% |
| Jan 31, 2022 | -1.09% |
| Oct 31, 2021 | -2.00% |
| Jul 31, 2021 | -4.90% |
| Apr 30, 2021 | -0.82% |
| Jan 31, 2021 | 34.14% |
| Oct 31, 2020 | 46.40% |
| Jul 31, 2020 | 50.52% |
| Apr 30, 2020 | 176.16% |
| Jan 31, 2020 | 185.61% |